Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Astagraf XL Dosing in African American Kidney Transplant Recipients
NCT02953873Phase 4Completed
- Sponsor
- Medical University of South Carolina
- Start
- May 2017
- Primary completion
- Sep 2018
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus in kidney transplant rejection, sponsored by Medical University of South Carolina. Started May 2017; status: completed.
02
Drugs
tacrolimus
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT02953873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02953873.